<SEC-DOCUMENT>0001104659-21-133637.txt : 20211103
<SEC-HEADER>0001104659-21-133637.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103160817
ACCESSION NUMBER:		0001104659-21-133637
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211103
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protagonist Therapeutics, Inc
		CENTRAL INDEX KEY:			0001377121
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980505495
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37852
		FILM NUMBER:		211375386

	BUSINESS ADDRESS:	
		STREET 1:		7707 GATEWAY BLVD., SUITE 140
		CITY:			NEWARK
		STATE:			CA
		ZIP:			94560-1160
		BUSINESS PHONE:		(510) 474-0170

	MAIL ADDRESS:	
		STREET 1:		7707 GATEWAY BLVD., SUITE 140
		CITY:			NEWARK
		STATE:			CA
		ZIP:			94560-1160

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Protagonist Therapeutics Inc
		DATE OF NAME CHANGE:	20130605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Protagonist Inc
		DATE OF NAME CHANGE:	20061002
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2131730d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ptgx="http://protagonist-inc.com/20211103">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_ptgx_protagonist%2Dinc.com_20211103 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20211103_20211103 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001377121 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityCentralIndexKey">0001377121</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ptgx-20211103.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-11-03to2021-11-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001377121</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-03</xbrli:startDate>
        <xbrli:endDate>2021-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20211103__20211103_zySI5VkyGbQ2"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>Date of Report (Date of earliest
event reported): <b><span id="xdx_906_edei--DocumentPeriodEndDate_c20211103__20211103_zVrsgdH0gxhg"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 3, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20211103__20211103_zwjCz0pIqryf"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityRegistrantName">PROTAGONIST THERAPEUTICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified
in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 35%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20211103__20211103_zgu4e4HYPyy4"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 28%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityFileNumber_c20211103__20211103_zHUz1IxkHUme"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityFileNumber">001-37852</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 35%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20211103__20211103_zXCxDpm2QEBd"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityTaxIdentificationNumber">98-0505495</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction<br />
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission<br />
File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br />
Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20211103__20211103_z8trCE8ird0c"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityAddressAddressLine1">Protagonist Therapeutics, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine2_c20211103__20211103_zGzRsUyQ6lue"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityAddressAddressLine2">7707 Gateway Blvd.</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine3_c20211103__20211103_zVgLugcFSVM1"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityAddressAddressLine3">Suite 140</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20211103__20211103_zI2rQbg7Ep6a"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityAddressCityOrTown">Newark</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20211103__20211103_zg7z5Sh10QA2"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20211103__20211103_z1DjXkIxJ0jf"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:EntityAddressPostalZipCode">94560-1160</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices,
including zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20211103__20211103_zK0Hr8yBxlc1"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:CityAreaCode">510</ix:nonNumeric></span>) <span id="xdx_90E_edei--LocalPhoneNumber_c20211103__20211103_zS3jIKBl5rz1"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:LocalPhoneNumber">474-0170</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 2%; text-align: left"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_901_edei--WrittenCommunications_c20211103__20211103_zTKdV2ftZipb"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify; width: 98%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 2%; text-align: left"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_902_edei--SolicitingMaterial_c20211103__20211103_znjtYrc4gPIc"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify; width: 98%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 2%; text-align: left"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementTenderOffer_c20211103__20211103_zFhnbmyy79ll"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify; width: 98%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 2%; text-align: left"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20211103__20211103_zJYR1PVh6fMf"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify; width: 98%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 35%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 28%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 35%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which<br />
registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--Security12bTitle_c20211103__20211103_z6zYMh9P2TI9"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:Security12bTitle">Common Stock, par value $0.00001</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20211103__20211103_zI6HMIfbleff"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" name="dei:TradingSymbol">PTGX</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--SecurityExchangeName_c20211103__20211103_zCieeE15d1r"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Emerging growth company </span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20211103__20211103_z3q2kuABoUo"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityExTransitionPeriod_c20211103__20211103_zeCi9hTkWbWb"><ix:nonNumeric contextRef="From2021-11-03to2021-11-03" format="ixt:booleantrue" name="dei:EntityExTransitionPeriod">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Wingdings; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Wingdings; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Wingdings; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><b>Item 2.02. Results of Operations
and Financial Condition.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">On November 3, 2021, Protagonist Therapeutics,
Inc. reported its financial results for the quarter ended September 30, 2021. A copy of the press release titled &#8220;Protagonist Therapeutics
Reports Third Quarter 2021 Financial Results and Provides Corporate Update&#8221; is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01 </b>&#160;<b>Financial Statements
and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 2%; font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 88%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2131730d1_ex99-1.htm"><span style="font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><a href="tm2131730d1_ex99-1.htm"><span style="font-size: 10pt">Press release, dated November 3, 2021, titled &#8220;Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.&#8221;</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information in this report, including the exhibit hereto, shall
not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of Section&#160;11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein
and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission
made by Protagonist Therapeutics, Inc., whether made before or after the date hereof, regardless of any general incorporation language
in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt"><span style="font-size: 10pt"><b>Protagonist Therapeutics, Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Dated: November 3, 2021</span></td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td rowspan="2" style="padding: 0.25pt; width: 50%">&#160;</td>
    <td style="padding: 0.25pt; width: 4%; font-size: 10pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; width: 46%; font-size: 10pt"><span style="font-size: 10pt">/s/ Don Kalkofen</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Don Kalkofen</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLNOFNybDhVxigwRX8sWpbg1I+2m+yT/0rohhkBI7j25QozElja6RIbrKkvhjFVdKoeQ4Q0ZTY7ekez2MfiZ4V1bx8q4fv2BCXkGPTMLp7m/985WWyxikPOxXIwjCXIaRzNYHkTw1RMyN12gcVqVoEwBJ6aaNTrF3fDhrF5kqOr6pAuy1WRimIRykN8QyUkER2rVk/hhIU0TEYz6CsSWqam/MY11VMG6xMpn2QH9d/AB1xxJDQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2131730d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><IMG SRC="tm2131730d1_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Protagonist Therapeutics
Reports Third Quarter 2021 Financial Results and Provides Corporate Update</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>Resumption of the Phase
2 study of rusfertide in polycythemia vera now underway, following swift removal of the FDA clinical hold</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>Positive proof -of-
concept data for rusfertide in hereditary hemochromatosis to be presented at The Liver Meeting<SUP>&reg;</SUP> hosted by the American
Association for the Study of Liver Diseases</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>PN-235 moves into a
psoriasis indication, Phase 2 study initiation planned for early 2022</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>NEWARK, Calif., November 3, 2021&mdash;</B>Protagonist
Therapeutics, Inc. (Nasdaq: PTGX) (&ldquo;Protagonist&rdquo; or &ldquo;the Company&rdquo;) today reported its financial results for the
third quarter ended September 30, 2021 and provided a corporate update.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;We are excited to share the substantial
progress made thus far in all of our clinical programs, highlighted by the presentation of proof-of-concept data on rusfertide in hereditary
hemochromatosis at the upcoming AASLD meeting, and the new rusfertide data in polycythemia vera, which will be presented by the year&rsquo;s
end,&rdquo; said Dinesh V. Patel, Ph.D., President and Chief Executive Officer. &ldquo;We were very pleased that the FDA reached a swift
resolution regarding the clinical hold placed on rusfertide, and we are in the process of resuming all rusfertide clinical studies. Additionally,
we are highly encouraged with the rate of enrollment in the Phase 2 study of our oral alpha-4-beta-7 integrin antagonist PN-943, for ulcerative
colitis, an indication with a large patient population and unmet treatment need. We maintain our guidance of a data readout in Q2 2022,
and in anticipation of this, we are excited that Dr. Scott Plevy has joined our team as Executive Vice President and Therapeutic Head,
Gastroenterology. As a renowned gastroenterologist, Dr. Plevy will oversee the clinical development of PN-943 and other future programs
focused on gastrointestinal diseases. Finally, our oral IL-23 receptor antagonist program, in partnership with Janssen, continues to make
demonstrated progress, with PN-235 now advancing into a Phase 2 study in psoriasis in early 2022.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Third Quarter 2021 Recent Developments
and Upcoming Milestones</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Rusfertide: Subcutaneous Injectable Hepcidin
Mimetic for Polycythemia Vera (PV) and Other Blood Disorders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On October 11, 2021, Protagonist announced that the U.S. Food and Drug Administration
(FDA) removed the full clinical hold on rusfertide&rsquo;s clinical studies after the Company provided the FDA with all requested information,
including the individual patient clinical safety reports, updated the investigator brochure and patient informed consent forms, conducted
a comprehensive review of the most recent safety database, and added new safety and stopping rules in the study protocols. This was in
response to the Company receiving a communication from the FDA that Protagonist&rsquo;s clinical studies for rusfertide had been placed
on clinical hold on September 17, 2021. Protagonist has been working closely with study investigators and clinical trial sites to resume
enrollment and dosing of patients in ongoing clinical trials with rusfertide.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">An
                                            abstract highlighting new, preliminary data from a Phase 2 proof-of-concept study in hereditary
                                            hemochromatosis (HH) has been selected for oral presentation by Dr. Kris Kowdley, from the
                                            Liver Institute Northwest in Seattle. These data will be presented on November 13, 2021 at
                                            The Liver Meeting<SUP>&reg;</SUP> 2021, hosted by the American Association for the Study
                                            of Liver Diseases (AASLD).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company intends to report updated data from the Phase 2 study of rusfertide
in polycythemia vera (PV) by the end of 2021.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company is on track to initiate the Phase 3 study of rusfertide in PV
in Q1 2022.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company resolved its collaboration agreement dispute with Zealand Pharma,
reducing future development and sales milestone payments and royalties owed to Zealand for rusfertide under the companies&rsquo; 2012
collaboration agreement. Under the new terms of the agreement, future development and sales milestone payments (other than $2.5 million
in near-term milestones) and royalties for rusfertide have been reduced by 50 percent. Milestones and royalty payments will be due for
sales and milestones achieved by either Protagonist or any future rusfertide licensee or partner. Protagonist will also make a $1.5 million
payment to Zealand in August 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>PN-943: Oral, gut-restricted, alpha-4-Beta-7
Integrin Antagonist for Ulcerative Colitis</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">We are continuing to see steady progress in the enrollment and execution
of the Phase 2 IDEAL study of PN-943 in ulcerative colitis. This study includes a 12-week induction period and a 40-week open label extension.
Topline data from the 12-week induction period is expected in the second quarter of 2022. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Scott Plevy, M.D., renowned expert in translational and clinical research
in gastroenterology and immunology, was appointed Executive Vice President and Therapeutic Head, Gastroenterology, and he will oversee
clinical operations and development of Protagonist&rsquo;s ongoing and future programs in gastrointestinal diseases, including PN-943.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Oral IL-23 Receptor Antagonists (collaboration
between Janssen Biotech, Inc. and Protagonist)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Following a pre-specified interim analysis criteria, a portfolio decision was made to stop further development of the
                                                                                                                                first-generation IL-23 receptor antagonist (IL-23R) candidate PTG-200 (JNJ-67864238), in favor of continued development of the two second
                                                                                                                                generation candidates PN-235 (JNJ-77242113) and PN-232 (JNJ-75105186) with superior product profiles. In particular:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&minus;</FONT></TD><TD>The Phase 1 study of&nbsp;PN-235 is completed, and a Phase 2 study in psoriasis is anticipated to initiate in early 2022.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&minus;</FONT></TD><TD>The Phase 1 study with
                                            PN-232 is under progress with study completion expected by mid-2022.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-size: 10pt">&minus;</FONT></TD><TD>Additional development in IBD is expected to initiate in 2022.</TD></TR>
                                                                                                                                                                                                                   </TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Protagonist will earn a $25 million milestone in connection with the initiation of the first Phase 2 study of a second-generation
candidate, and a $10 million milestone in connection with the initiation of the second Phase 2 study of a second-generation candidate.&nbsp;Protagonist
remains eligible for up to approximately $900 million&nbsp;in development-related milestone payments, in addition to the $87.5M in milestones
already earned.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Protagonist received a $7.5 million milestone payment from Janssen, triggered by the completion of the clinical data collection Phase
1 activities for PN-235 (JNJ-2113).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Third Quarter 2021 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Cash, Cash Equivalents and Marketable Securities</B>: Cash, cash equivalents and marketable securities as of September 30, 2021,
were $352.5 million. The Company expects current cash, cash equivalents and marketable securities to be sufficient to fund its planned
operating and capital expenditures through 2024.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD><B>License and Collaboration Revenue: </B>License and collaboration revenues were $10.3 million and $18.7 million for the three and
nine months ended September 30, 2021, respectively, as compared to $13.1 million and $23.0 million reported for the same periods of 2020.
The Company recognized $8.0 million as a cumulative catch-up amount during the three months ended September 30, 2021, following the amendment
of its collaboration agreement for the development of IL-23 receptor antagonist assets with Janssen Biotech. This cumulative catch-up
was primarily the result of an acceleration of our cumulative performance completed under our obligation, following the amendment to the
collaboration which reduced the remaining services the Company is responsible to conduct. We are nearing completion of our remaining services
to be provided to Janssen under the collaboration, in particular, both the ongoing Phase 1 trials in PN-235 and PN-232, are expected to
be complete in the fourth quarter of 2021 and second quarter 2022, respectively. Revenue for the prior year&rsquo;s third quarter of 2020
also included an estimate update for services completed versus remaining services to be performed under the Janssen collaboration agreement
which accelerated revenue recognition.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD><B>Research and Development (&ldquo;R&amp;D&rdquo;) Expenses:</B> R&amp;D expenses for the three and nine months ended September 30,
2021, were $37.0 million and $87.6 million, respectively, as compared to $16.0 million and $55.0 million, respectively, for the same periods
of 2020. The increases were primarily due to additional costs associated to advancing our clinical trials with our pipeline assets rusfertide
and PN-943, as well as our second-generation IL-23 receptor antagonist assets under the Janssen collaboration (PN-235 and PN-232). The
increases also relate to higher research spending and employee related costs, including stock-based compensation expenses following recent
hiring in support of our advancing research and development programs. Following the amendment to the Zealand collaboration agreement we
also recorded $4.0 million in the quarter ended September 30, 2021 in R&amp;D expense related to these collaboration payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD><B>General and Administrative (&ldquo;G&amp;A&rdquo;) Expenses:</B> G&amp;A expenses for the three and nine months ended September
30, 2021, were $7.3 million and $19.9 million, respectively, as compared to $4.9 million and $13.6 million for the same periods of 2020.
The increases were primarily related to professional fees, insurance costs and employee compensation related expenses, including stock-based
compensation expenses, supporting the growth in our operations.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD><B>Stock Based Compensation (&ldquo;SBC&rdquo;) Expenses: </B>SBC expenses for the three and nine months ended September 30, 2021,
were $4.8 million and $11.4 million, respectively, as compared to $1.8 million and $5.9 million, respectively, for the same periods of
2020. SBC increases included in R&amp;D and G&amp;A expenses are primarily attributable to the addition of new employees and related stock
grants in support of the Company&rsquo;s continued growth coupled with the increase in the Company&rsquo;s stock price at grant date which
is used in the SBC expense calculation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD><B>Net Loss:</B> The third quarter 2021 net loss was $33.8 million, or a net loss of $0.70 per share, and the nine months ended September
30, 2021, net loss was $88.6 million, or a net loss of $1.94 per share, compared to the third quarter of 2020 net loss of $7.8 million,
or a net loss of $0.21 per share, and the nine months ended September 30, 2020, net loss of $47.3 million, or a net loss of $1.45 per
share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><B>About Protagonist</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">Protagonist Therapeutics is a biopharmaceutical
company with multiple peptide-based investigational new chemical entities in different stages of development, all derived from the Company's
proprietary technology platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">Protagonist's pipeline includes rusfertide
(PTG-300), an investigational, injectable hepcidin mimetic currently in a Phase 2 proof-of-concept clinical trial for polycythemia vera
(PV), a Phase 2 study in PV subjects with high hematocrit levels, and a Phase 2 study for hereditary hemochromatosis. The Company plans
to initiate a single, global Phase 3 randomized, placebo-controlled trial evaluating the efficacy and safety of a once weekly, subcutaneously
self-administered dose of rusfertide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">The Company is also evaluating an orally
delivered, gut-restricted alpha-4-beta-7 integrin specific antagonist peptide (PN-943) currently in a Phase 2 study in adults with moderate
to severe active ulcerative colitis (UC). The Company is targeting ulcerative colitis as the initial indication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">The Company has a worldwide license
and collaboration agreement with Janssen Biotech, Inc., for the development of oral peptide IL-23 receptor antagonists. Compounds in development
include PN-235 and PN-232, both second-generation oral interleukin-23 receptor antagonist candidates. The Phase 1 study of&nbsp;PN-235
is completed, and Janssen is expected to initiate a Phase 2 study in psoriasis in Q1 2022. The phase 1 study with PN-232, the second 2nd
generation candidate, is under progress with study completion expected by mid-2022. Additional research in IBD is expected to initiate
in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Protagonist is headquartered in&nbsp;Newark,&nbsp;California.
For further information, please visit&nbsp;<FONT STYLE="color: black">www.protagonist-inc.com</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><B>Cautionary Note on Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">This press release contains forward-looking
statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements regarding our intentions or current expectations concerning, among other things, the Company&rsquo;s clinical development
program for rusfertide. In some cases, you can identify these statements by forward-looking words such as &quot;anticipate,&quot; &quot;believe,&quot;
 &quot;may,&quot; &quot;will,&quot; &quot;expect,&quot; or the negative or plural of these words or similar expressions. Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events
to differ materially from those anticipated, including, but not limited to, our ability to develop and commercialize our product candidates,
our ability to earn milestone payments under our collaboration agreements, the impact of the current COVID-19 pandemic on our discovery
and development efforts, our ability to use and expand our programs to build a pipeline of product candidates, our ability to obtain and
maintain regulatory approval of our product candidates, our ability to operate in a competitive industry and compete successfully against
competitors that have greater resources than we do, and our ability to obtain and adequately protect intellectual property rights for
our product candidates.&nbsp; Additional information concerning these and other risk factors affecting our business can be found in our
periodic filings with the&nbsp;Securities and Exchange Commission, including under the heading &quot;Risk Factors&quot; contained in our
most recently filed periodic reports on Form 10-K and Form 10-Q filed with the&nbsp;Securities and Exchange Commission. Forward-looking
statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the
development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release.&nbsp;
Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation
to update our forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press
release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt; background-color: white">Company: Jami
Taylor &ndash; <U>j.taylor@ptgx-inc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Investors: Kevin Murphy &ndash; <U>protagonist@argotpartners.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Media: Joshua R. Mansbach &ndash; <U>protagonist@argotpartners.com</U></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>PROTAGONIST THERAPEUTICS,
INC.<BR>
Condensed Consolidated Statements of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>(Unaudited)<BR>
(Amounts in thousands except share and per share data)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">License and collaboration revenue - related party</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">10,286</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">13,114</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">18,740</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">22,978</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-left: 9px">Research and development <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">36,956</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,995</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">87,633</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55,020</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 9px">General and administrative <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,256</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,891</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">19,936</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">13,644</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 18px">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">44,212</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,886</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">107,569</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">68,664</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Loss from operations</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(33,926</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,772</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(88,829</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(45,686</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest income</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">122</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">87</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">321</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">820</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(19</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(471</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss on early repayment of debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(585</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other expense, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(59</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(136</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(37</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss before income tax expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(33,804</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,763</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(88,644</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(45,959</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,305</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(33,804</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,763</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(88,644</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(47,264</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net loss per share, basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.70</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1.94</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1.45</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted-average shares used to compute net loss per share, basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">47,987,184</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">37,386,881</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">45,705,782</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">32,647,524</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; color: Red; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"><SUP>(1)</SUP></TD><TD>Amount includes non-cash stock-based compensation expense.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt"><B>PROTAGONIST THERAPEUTICS,
INC.<BR>
<FONT STYLE="background-color: white">Stock-based Compensation </FONT>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt"><FONT STYLE="background-color: white"><B>(In
thousands)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Research and development</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2,611</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,006</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">6,241</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,098</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,164</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">882</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,130</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,834</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,775</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,888</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">11,371</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,932</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>PROTAGONIST THERAPEUTICS,
INC.<BR>
Selected Consolidated Balance Sheet Data<BR>
(In thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 82%; font: 10pt Times New Roman, Times, Serif; margin-right: 1.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><B>2020</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Cash, cash equivalents and marketable securities</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">352,470</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">307,809</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Working capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">288,531</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">275,365</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Total assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">373,175</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">324,468</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred revenue-related party</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,241</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,477</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Accumulated deficit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(372,455</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(283,811</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total stockholders' equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">329,660</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">279,606</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ptgx-20211103.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWayOubOdzZR++YkxtmB8balqvyEnfuHDgizTlQlW8fwM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:ptgx="http://protagonist-inc.com/20211103" elementFormDefault="qualified" targetNamespace="http://protagonist-inc.com/20211103">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://protagonist-inc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ptgx-20211103_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ptgx-20211103_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ptgx-20211103_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ptgx-20211103_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://protagonist-inc.com/role/Cover" xlink:href="ptgx-20211103.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://protagonist-inc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2131730d1_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2131730d1_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. /H# 2(  A$! Q$!_\0
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M9)8JHQQ\V68 #) &3DY'&#FC[3#D#>OS,44[TPS!6?:OS<ML21]HRVR-VQM
M) )Z*A$\9!(S@8YRI!R-Q*D,0P Y)!([ D@@'VB+@;ADYP-RGHQ3LQ !<%,G
MC<""1QD FII95!9F  ZDG '.#D]@#P3T'>HQ.A 9<LIQ@C!!R,\'.,@9)'4
M9P<KNX;XFR^,$^&OQ!F^&\5I=?$"/P1XN;P'#?/9K83^-1HE\WA:*]>^N+:P
M6S?7A8Q73WMS;V:1%S=SPVXDE4 [W>F0-PR3@#W^88^OR/\ ]\GTIV>OMP?R
MS_(BOR3_ ."2VK_\%1M6^"/CJ\_X*R^&/ 7A+X^Q_&"^M_!-G\/+SX9W6B7G
MP?A\">#'TV\OI/A?XD\4:,-83QLOC6TN8[^[M=4\FVM7%N--6VGF_6-;B%5;
MYE+1@"10R$@C<F6.X*!F*1<D@;HW&?E)H LTW<O]X?G_ )]#SVP?0U5ENHU2
M1U)D:-7S&I#%V3<&CV@GYQAB0<<*V2 C[?RG^%__  4]C^)7_!7'X\_\$KE^
M";Z)-\$/V8[3]I*;XZ-\1([^'Q+%=^(O@WHD/A"'X:Q^"[?^RMJ?%G[;_P )
M$_C[4"QT(1'0HSJK_P!F@'ZR45'YJ>O/)QE>@_'OE>O]X9QAMK\CU'YB@"K<
MHC+$' "^=&2<D%<87"NK*4]"01W&"3M/^1!X?\-:!\:O^#C#5_!/_!1][=M
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M^,)=;.M_M)?%?4=>DN= T_Q2D3>(])\'^&+O7]3T^&^UIBT.I^,_$4VM^+C
M][9:%?\ AW1M6UC2+W\O;#X.^ _BU_P>0?$;4?'/AZS\0M\'?V0/!GQ?\&17
MRB>TTOQWHGPZ^''A?0?$ M2KI+J.BQ^,+Z]TJ60I]@U&*"[BC,]O \8![Y^S
MA\3?^"PG['.O_M(_\%*_^"WGQM^#?A+]D;PW^RUXK_X1K]DKX5>)-,GNOA[\
M9]2\<_"G6/ .A:7X7\-^$KOPYJ/B?4-(TWQIX%L->O/BY\0O$4^O^+(K=;J\
MT6[:XT[PSX$/_P %[/\ @M)X.L_VKM"_:JT+_@D_^R-XRF;4OV=OA[\+O H\
M;_%CXG^$/M6N6%KXX\;>(9KFV\5169ACM1IEY>:QH>A^+[-/[;T7P'I^F1:+
MXFU?V[_@\(EU.W_X)B?",2)JLG@&7]N[X")\84TI'E#?#E/AY\<I[O[:\9^T
MVT#^*X/!T=O-;2P7+:N-+A2;$Q5_Z;?@Y>_#Z\^$GPMO/A;<^&[CX8WGPY\$
MW'PVG\)7&G7'A2?P%+X7TR?PA-X6FTDG29_#I\-?V;/H\NF;M.?3F@-DQMR@
M(!_)):_\%"/^"I__  1*_:+^#'PA_P""M?CGPE^V/^PS\;_&2>#O _[=/A3P
MI'X;\=_#FX;1CI>G:;\1-)T73-#BN[JPOET_7O$&D^,G\1>);CPW<>)->T#X
M@>+;_1Y/#FG^?_\ !WI\//VI]6_9D\)_&_2/VH-#'[%EW\0/@%X7/[+=O\-?
M"=[?:S\9I_\ A;&I:=\:K7XR?81XPFT4>&KO3=-B\'6FKOH-]);-J?EEUBNY
M?TO_ .#JF+P7+_P1,_:QD\4MH)UJW\5_LUR_#;^TYK9=0_X3<_M"_#:"^/AI
M97$TVL_\*XF\?&:.W$DX\.GQ%*R_9H+EX_S0_P""_">,H_\ @VE_8&C^(9>;
MQXFJ?L%KXO,BW(<^(O\ A1GB?^U8Y$N]UTDBW9E1Q<!9=W#HC'RP ?J!^QM^
MQK_P6\\'^+?V<_'OQK_X+"^!_B]^SQHT/@'7/&?P(L/V,?@QX'NO%W@%-!L9
M1X*M_B%H/A>Q\0:-,MB]K"NO6]W;WCRV_P!IN7$D\I;?_;9^$?\ P7M_:"_:
M?\5^!/V0OVHOV;/V*/V+]&TOP]+X:^,0\&P?$_\ :"\<:GJW@F$>(_#FK>$O
M%/AKQ)IFF6^B^/7O;:SU/1Y_ NHP^'+CP_XDLM:UV:>]T6T_;;X22"#X0?"E
M2 \G_"M_ R"-BV3_ ,4GIY*L$!8,1')D["&)56'RJ5_E ^'?[7'_  5W_P""
MT7[2W[7VE?L'_M*^ O\ @G[^Q;^R[\5+OX%0^+_^%5>"_B?\7OBYXUTQKU=6
MOGUCQ/I?B672+FU_LD:ZDGA>]\':;8>%_$>@Z(;CQ%K,FI7L(!YC^TY\6_\
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M\ZK'+=VFGZ[X6\1>$/%UOI.L02G29-<?1I;C4OL?G3_L=,BF&=0O!A=<G/\
M=D!'/IZCD@CJ *_D0_X-0[BX/[#?_!1W3S,WV*R_X*%_M#74%OA=D4]Y\'/A
M3;W4JXY5IH["R5^2-ML@'<D [S_@A[_P58_:#^+?_!&S]KC_ (* ?MQ?$+5?
MCKXQ_9T\?_'+5&NM.\+>!/ &JZUX0^&/PD\ >-M&\$Z?9_#GP=X<\.V=[J^N
M:G?:?!KMSH%S)#)JL4^KR75C8(L/AG[+WP]_X+E_\%@/@GH?[=T__!3#2_\
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MM9>.M+\9^%)O"O@;P3\/]-CTRT^&?P\\.V>HZKX_\8^(;U;[Q#KFJ^%K;1]
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MNO6XTF^U#0M%\0Z%XAC\/ZO>^&/$NB:>R(WA;5?%.EZC\%>#O^"P_P#P6_\
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M/T#1O"FYHG[*G[2%O_P=.^*OVN9?@I\0$_9FO_V,[+P1:_&T:%<#X?S>+?\
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M_@M;X'\?:G\*/VN/V.OV8/CY:>$8Y;?Q+\3/@;\9)-%U:1X&(FU-5^$.A?M
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M1GD<5)12LG:Z3L[Z_P"6S^::\@:O==U;33\5JODT>%?&;P9X:UGP1X[U?6=
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M$1UK3YM)M=-B@NIO%%@-,6TUG46F2.[:YAM)XX8G659-FF6U8T,!@,VP\O\
M7#,L=BZ^*K8O$T)8+$T,Y^J3H*OB:\J=&52>$BU0]E'EC[YQ9KF^59E2E7Q>
M)RFI?@O*\!@(X+"T,#7I9GE^-X>HXVEBOJ^$PZGBY4:69U(U<2ZL)TJEZ=Y^
MRY?E#X=ZA^UW^T]X6N?CKX-^.OAKX(^#_$.IZU/\'OAP_P -;+Q@-0\+:9KE
MUI5AJ7Q+UV^U6TU!-6U\:7-<3V6C6-U9:0UW#=)+JQ4V=RG[4?QI^,OPIE^
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%B[ ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2131730d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ptgx-20211103.xsd" xlink:type="simple"/>
    <context id="From2021-11-03to2021-11-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001377121</identifier>
        </entity>
        <period>
            <startDate>2021-11-03</startDate>
            <endDate>2021-11-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-11-03to2021-11-03">0001377121</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-11-03to2021-11-03">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-11-03to2021-11-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-11-03to2021-11-03">2021-11-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-11-03to2021-11-03">PROTAGONIST THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-11-03to2021-11-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-11-03to2021-11-03">001-37852</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-11-03to2021-11-03">98-0505495</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-11-03to2021-11-03">Protagonist Therapeutics, Inc.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-11-03to2021-11-03">7707 Gateway Blvd.</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2021-11-03to2021-11-03">Suite 140</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2021-11-03to2021-11-03">Newark</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-11-03to2021-11-03">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-11-03to2021-11-03">94560-1160</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-11-03to2021-11-03">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-11-03to2021-11-03">474-0170</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-11-03to2021-11-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-11-03to2021-11-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-11-03to2021-11-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-11-03to2021-11-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-11-03to2021-11-03">Common Stock, par value $0.00001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-11-03to2021-11-03">PTGX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-11-03to2021-11-03">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-11-03to2021-11-03">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-11-03to2021-11-03">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139680912087560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  03,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROTAGONIST THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001377121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0505495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Protagonist Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">7707 Gateway Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newark<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94560-1160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">474-0170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PTGX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  (@6-3EXJ[',
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MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    "  (@6-3)!Z;HJT
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M2P$"% ,4    "  (@6-3!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  B!8U, XF_I[0   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M  B!8U.97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ "(%C4UJTBR&@!   .!(  !@
M     ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M  B!8U.?H!OPL0(  .(,   -              "  >(,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ "(%C4Y>*NQS     $P(   L              ( !
MO@\  %]R96QS+RYR96QS4$L! A0#%     @ "(%C4ZK$(A8S 0  (@(   \
M             ( !IQ   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  B!
M8U,D'INBK0   /@!   :              "  0<2  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  B!8U-ED'F2&0$  ,\#   3
M          "  >P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  #84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2131730d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagonist-inc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2131730d1_8k.htm">tm2131730d1_8k.htm</File>
    <File>ptgx-20211103.xsd</File>
    <File>ptgx-20211103_lab.xml</File>
    <File>ptgx-20211103_pre.xml</File>
    <File>tm2131730d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2131730d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2131730d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ptgx-20211103_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ptgx-20211103_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ptgx-20211103.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ptgx",
   "nsuri": "http://protagonist-inc.com/20211103",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2131730d1_8k.htm",
      "contextRef": "From2021-11-03to2021-11-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://protagonist-inc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2131730d1_8k.htm",
      "contextRef": "From2021-11-03to2021-11-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://protagonist-inc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-21-133637-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-133637-xbrl.zip
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MNAA?+&;S^0BE&68QIIR13R/&1S_]^.<_(?GS\2_C,;I*"(W/T1<>C>?L@?^
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ML7T;OK[K6F[)W7J7_+7"*9%[_@M02P,$%     @ "(%C4]408 %>!P  15D
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M^#&HC_^6'M97M8C##G%4-I>78$C^$X5_QR>-%REL"KS6;6P@,B8J&.LG7KL
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MRHZ%F#YT#0>;Q'*9,4$,DAG6G8BA_@BK SSU<AQ_ERQ41G8!$/#3G 1M7<L
M['P<]Z\Z3_W8_L?Q<58L#1='YXNG[T3ZVD,[JVH*4=E\<!FDC9/E153EK^@
M@W2=F-0UV<5#W9CLH^\P33YU]J9.BWG'=ZH[(!D\9W=-/ZUE\3:[?:[=*5T'
M8HC.6G8)EYWRC"7)$X+BP5*#'OU855SPUV.ZIJ4B+*F/&"83QHSLT%XUWQY
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M%J=D7[HHRNN^NCE]23$2\].9'_*%3I7[%0LO!O+"GSW$^M@PMK=X7:-#D$;
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MX3][UR?7I\>?]C[(?\.O']3/>P?G1_]A5]?_.3W^;:/KN>%'5JT,0W9M#T3
MSL2(77H#[AKR@<&NA&]W-^!#^/3BKM_ML@'W>[;[D>&KE5T6BE]AB3MV#Q[Y
M=J\?JD>V:PD<LF*[&Y_V#CX=_^K;'3MD.SOEZMZ' UC(Q;."\-[M!,/=YYYU
M[^3K[^SJ\O"WC7!0J]:KK7K%JOZO^+6S4ZK:@UZE6OY[V-M@^Z?7OVUL+!M.
M&@^:U81YA+_+.MS\T?.]R+5*IN=X_D<VZMNA(**X\+V0]SS7#F"FOO#Y4$2A
M;0;%PJ48>GX8P%/;M]B?$?=A,%:KU*KLL^URU[2YPRY%$#GP$G<M!D/=V!;
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M";5*F0X3ZT7N7L\%O,)@;6TLS+L MPWHQ!XF#WEH]DM@X_,!4$7(+& L=8A
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M^#J%_AT<M;O3#*C]G7;+J+8?D?7NZ?2N!D+K+:/>WC;:[4?4!F\:H8VFT:K
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MV^NMNE'-QZ-6@)#JM8;1V,Z%B%Z))#H27>'[X(:JVYI+M][5O#Q8KTW+R*X
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M@T>C/GRY_GKZZ?\!4$L! A0#%     @ "(%C4_Y-Q?)( P  IPP  !$
M         ( !     '!T9W@M,C R,3$Q,#,N>'-D4$L! A0#%     @ "(%C
M4W >C @!"P  XH<  !4              ( !=P,  '!T9W@M,C R,3$Q,#-?
M;&%B+GAM;%!+ 0(4 Q0    (  B!8U/5$& !7@<  $59   5
M  "  :L.  !P=&=X+3(P,C$Q,3 S7W!R92YX;6Q02P$"% ,4    "  (@6-3
M!)[%KN$2   R:@  $@              @ $\%@  =&TR,3,Q-S,P9#%?.&LN
M:'1M4$L! A0#%     @ "(%C4W)O-S A(@  *PH! !8              ( !
M32D  '1M,C$S,3<S,&0Q7V5X.3DM,2YH=&U02P4&      4 !0!) 0  HDL
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
